Leo Pharma has promoted current senior VP Anders Spohr to the position of executive VP for global product supply.
On March 1, 2012, Spohr will take over from John Mehlbye at the Denmark-based pharma firm, with Mehlbye to continue on the board of directors of the Leo Foundation, which owns Leo Pharma.
Spohr only joining Leo Pharma in December, moving from Danish biotech Novozymes where he spent 11 years, serving as vice president of enzymes business supply chain management, production director for Novozymes North America and director of product and technology co-ordination.
Previously, Spohr worked at Novo Nordisk from 1997 to 2000, before Novozymes separated from Novo Nordisk to become its own independent company.
In his new role at Leo, he will have responsibility for ensuring flexible, efficient and streamlined production processes to support the pharma company's operations in more than 100 countries.
No results were found
Blending brilliant writing with in-depth market access and reimbursement expertise...